News Archive

  • New support for VIDO as a research facility of national importance

    The benefit of VIDO’s cutting-edge infrastructure has been acknowledged through funding from the Canada Foundation for Innovation Major Science Initiatives Fund.

  • VIDO: Advancing human, animal health at home and abroad

    VIDO is committed to protecting Canada and the world from infectious diseases, in both animals and humans. Approximately 70 per cent of the pathogens that affect humans come from animals.

  • New VIDO Vaccine Development Centre supports vaccine innovation protecting Canadians, animals

    USask's Vaccine and Infectious Disease Organization has completed the construction of its Vaccine Development Centre, strengthening and expanding Canada’s domestic biomanufacturing capacity.

  • VIDO: Saskatchewan’s gift to global health

    The opening of its new Vaccine Development Centre advances VIDO’s position as Canada’s Centre for Pandemic Research.

  • USask hosts the Prime Minister of Canada

    Prime Minister Justin Trudeau paid tribute to the contributions the University of Saskatchewan has made to scientific discovery, as he wrapped up his visit to campus on Wednesday.

  • A new opportunity to develop livestock and human vaccine in Saskatchewan: SARM supports VIDO‘s effort to strengthen the response to infectious disease

    The Saskatchewan Association of Rural Municipalities Board of Director’s met with VIDO in January, to discuss the ways rural municipalities can support and strengthen the world’s response to infectious diseases.

  • Developing oral vaccine for chronic wasting disease goal of funding research

    Prion disease poses significant risk to wildlife, but research into developing vaccine cause for optimism.

  • Investments in USask livestock research fuels innovation, protects animal health

    University of Saskatchewan (USask) researchers have been awarded $4.2 million to develop livestock-related innovations that range from improving forage feed to advancing work on vaccines to tackle the global spread of African swine fever (ASF).

  • Saskatoon hospital foundations offer support to USask’s VIDO

    Three of Saskatoon’s hospital foundations have partnered to donate $230,000 in support of Canada’s Centre for Pandemic Research at VIDO.

  • CEPI awards USask’s VIDO $6M for vaccine development

    VIDO at USask has received approximately CAN$6 million from the Coalition for Epidemic Preparedness Innovations. This is CEPI’s first ever award to a Canadian university.